10x Genomics (TXG) Research Hub

10x Genomics (TXG) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-09-11, shares last closed at 68.59 USD (+1.93%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -276.76, market cap 6.07B. This hub links to the full technical, earnings and options research available for TXG.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Healthcare Information Services)
ExchangeNASDAQ, US
Last close68.59 USD (+1.93%)
52-week range29.66 USD – 69.67 USD
Trend regimeRange
14-day RSI78.6 (Overbought)
Trailing P/E-276.76
Market cap6.07B
Dividend yield0.00%
Next earnings2026-08-06

Available research for TXG

Earnings

TXG earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Hold, P/E -276.76. Updated 2026-07-23.

Options: Covered Call

Covered Call on TXG: how it works, illustrative setup around the real 68.59 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on TXG: how it works, illustrative setup around the real 68.59 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on TXG: how it works, illustrative setup around the real 68.59 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

TXG technical analysis: range, last 68.59 USD, RSI 78.6, 52w range 29.66 USD–69.67 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is TXG in?

10x Genomics (TXG) is classified under Healthcare (Medical - Healthcare Information Services), listed on NASDAQ, US.

Is TXG in an uptrend or downtrend?

As of 2026-09-11, TXG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is TXG's trailing P/E ratio?

TXG's trailing P/E is -276.76, with a market cap of 6.07B. See the earnings research page for full valuation detail.

When does TXG next report earnings?

TXG is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.23 USD.